BriaCell Therapeutics BCTX
NASDAQ BCTX
$4.07 +0.14 (+3.56%)
At close: Aug 21, 2026 · 4:00 PM EDT

BriaCell Therapeutics Corp. (BCTX) Other Accumulated Expenses (2021)

BriaCell Therapeutics (BCTX) posted Other Accumulated Expenses of $80967.0 for Q3 2021.

BriaCell Therapeutics Corp. (BCTX) Other Accumulated Expenses (2021) Analysis & Trends

BriaCell Therapeutics has reported Other Accumulated Expenses for 1 years, with the latest figure at $80967.0 in Q3 2021.

  • Quarterly Other Accumulated Expenses changed N/A year-over-year to $80967.0 in Q3 2021, while the trailing twelve-month figure through Jul 2021 was $80967.0 (changed N/A YoY) and the FY2021 annual result came in at $80967.0, changed N/A from the prior year.
  • Other Accumulated Expenses held at $80967.0 in Q3 2021 per BCTX's latest filing.
  • Over five years, Other Accumulated Expenses peaked at $80967.0 in Q3 2021 and troughed at $80967.0 in Q3 2021.

Peer Comparison

Historic Data

Download Data
DateValue
Jul 31, 2021 80,967.00